These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 29361415)

  • 21. Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy.
    Ito Y; Miwa S; Shirai M; Kanai M; Fujita K; Ohba H; Iwaizumi E; Oshima T; Kojima S; Suda T; Hayakawa H
    Respir Med; 2020 Aug; 169():106025. PubMed ID: 32442113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of Macrolide Resistance and Reinfection in Refractory Mycobacterium avium Complex Lung Disease.
    Jhun BW; Kim SY; Moon SM; Jeon K; Kwon OJ; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Am J Respir Crit Care Med; 2018 Nov; 198(10):1322-1330. PubMed ID: 29877739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical efficacy of a clarithromycin-based regimen for Mycobacterium avium complex disease: A nationwide post-marketing study.
    Kadota JI; Kurashima A; Suzuki K
    J Infect Chemother; 2017 May; 23(5):293-300. PubMed ID: 28254517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease.
    Jeong BH; Jeon K; Park HY; Kim SY; Lee KS; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Am J Respir Crit Care Med; 2015 Jan; 191(1):96-103. PubMed ID: 25393520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimen.
    Koh WJ; Hong G; Kim SY; Jeong BH; Park HY; Jeon K; Kwon OJ; Lee SH; Kim CK; Shin SJ
    Antimicrob Agents Chemother; 2013 May; 57(5):2281-5. PubMed ID: 23478956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycobacterium avium complex pulmonary disease: management options in HIV-negative patients.
    Ramirez J; Mason C; Ali J; Lopez FA
    J La State Med Soc; 2008; 160(5):248-54; quiz 254, 293. PubMed ID: 19048978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility testing of Mycobacterium avium complex isolates.
    Heifets L
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1759-67. PubMed ID: 8843278
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung Disease.
    Moon SM; Park HY; Kim SY; Jhun BW; Lee H; Jeon K; Kim DH; Huh HJ; Ki CS; Lee NY; Kim HK; Choi YS; Kim J; Lee SH; Kim CK; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6758-6765. PubMed ID: 27572413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo activities of clarithromycin against Mycobacterium avium.
    Fernandes PB; Hardy DJ; McDaniel D; Hanson CW; Swanson RN
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1531-4. PubMed ID: 2530933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive Cases.
    Morimoto K; Namkoong H; Hasegawa N; Nakagawa T; Morino E; Shiraishi Y; Ogawa K; Izumi K; Takasaki J; Yoshiyama T; Hoshino Y; Matsuda S; Hayashi Y; Sasaki Y; Ishii M; Kurashima A; Nishimura T; Betsuyaku T; Goto H;
    Ann Am Thorac Soc; 2016 Nov; 13(11):1904-1911. PubMed ID: 27513168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of Mycobacterium avium Complex (MAC).
    Griffith DE
    Semin Respir Crit Care Med; 2018 Jun; 39(3):351-361. PubMed ID: 30071550
    [No Abstract]   [Full Text] [Related]  

  • 32. Changes in serum immunomolecules during antibiotic therapy for Mycobacterium avium complex lung disease.
    Kim SY; Koh WJ; Park HY; Jeon K; Kwon OJ; Cho SN; Shin SJ
    Clin Exp Immunol; 2014 Apr; 176(1):93-101. PubMed ID: 24354934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermittent Antibiotic Therapy for Recurrent Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.
    Jhun BW; Moon SM; Kim SY; Park HY; Jeon K; Kwon OJ; Huh HJ; Ki CS; Lee NY; Chung MJ; Lee KS; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease.
    Fukushima K; Kitada S; Komukai S; Kuge T; Matsuki T; Kagawa H; Tsujino K; Miki M; Miki K; Kida H
    Sci Rep; 2021 Jan; 11(1):1178. PubMed ID: 33441977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of intermittent maintenance therapy after successful treatment of Mycobacterium avium complex lung disease.
    Asakura T; Nakagawa T; Suzuki S; Namkoong H; Morimoto K; Ishii M; Kurashima A; Betsuyaku T; Ogawa K; Hasegawa N;
    J Infect Chemother; 2019 Mar; 25(3):218-221. PubMed ID: 30172726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The macrolides: erythromycin, clarithromycin, and azithromycin.
    Alvarez-Elcoro S; Enzler MJ
    Mayo Clin Proc; 1999 Jun; 74(6):613-34. PubMed ID: 10377939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clarithromycin against Mycobacterium avium complex infections.
    Heifets LB
    Tuber Lung Dis; 1996 Feb; 77(1):19-26. PubMed ID: 8733409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.
    Miwa S; Shirai M; Toyoshima M; Shirai T; Yasuda K; Yokomura K; Yamada T; Masuda M; Inui N; Chida K; Suda T; Hayakawa H
    Ann Am Thorac Soc; 2014 Jan; 11(1):23-9. PubMed ID: 24298907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clarithromycin treatment for Mycobacterium avium-intracellulare complex lung disease.
    Frothingham R
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1990-1. PubMed ID: 8665069
    [No Abstract]   [Full Text] [Related]  

  • 40. Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.
    Cynamon MH; Carter JL; Shoen CM
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2895-6. PubMed ID: 10991883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.